Evidence map›Paper›PMID 24468737›Full record

ReviewSeminars in cancer biology2014

Epigenetic regulation of EBV persistence and oncogenesis.

Italo Tempera, Paul M Lieberman

Open access · greenAbstract readReview
In one paragraph

Review in Seminars in cancer biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 1 synthesis or guideline pooled it, 128 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Viral remodeling of the 4D nucleome.Experimental & molecular medicine · 2024
    Review
  20. Review

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Italo TemperaThe Fels Institute, Department of Microbiology and Immunology, Temple School of Medicine, Philadelphia, PA 19140, United States. Electronic address: Tempera@temple.edu.
Paul M LiebermanThe Wistar Institute, Philadelphia, PA 19140, United States. Electronic address: Lieberman@wistar.org.
Temple University · USThe Wistar Institute · US

Funding

Regulation of Epstein-Barr Virus LatencyR01CA093606 · NCI · WISTAR INSTITUTE · PI LIEBERMAN, PAUL M. · 2002 to 2022
$6.7M
Epigenetic Regulation of Epstein-Barr Virus Latency ProgramsR01DE017336 · NIDCR · WISTAR INSTITUTE · PI PAUL M. LIEBERMAN · 2005 to 2026
$6.5M
Regulation of EBV Latency by Chromosome ConformationR00AI099153 · NIAID · TEMPLE UNIV OF THE COMMONWEALTH · PI TEMPERA, ITALO · 2013 to 2014
$498k
NCI NIH HHS R01 CA093606NCI NIH HHS R01CA093606NIAID NIH HHS R00 AI099153NIAID NIH HHS R00AI099153NIDCR NIH HHS R01 DE017336NIDCR NIH HHS R01DE017336
6 · The paper itself

Abstract

Epigenetic mechanisms play a fundamental role in generating diverse and heritable patterns of viral and cellular gene expression. Epstein-Barr virus (EBV) can adopt a variety of gene expression programs that are necessary for long-term viral persistence and latency in multiple host-cell types and conditions. The latent viral genomes assemble into chromatin structures with different histone and DNA modifications patterns that control viral gene expression. Variations in nucleosome organization and chromatin conformations can also influence gene expression by coordinating physical interactions between different regulatory elements. The viral-encoded and host-cell factors that control these epigenetic features are beginning to be understood at the genome-wide level. These epigenetic regulators can also influence viral pathogenesis by expanding tissue tropism, evading immune detection, and driving host-cell carcinogenesis. Here, we review some of the recent findings and perspectives on how the EBV epigenome plays a central role in viral latency and viral-associated carcinogenesis.

Indexed as

Cell Transformation, NeoplasticEpigenesis, GeneticGene Expression Regulation, ViralCell Transformation, ViralChromatinDNA MethylationEpstein-Barr Virus InfectionsGenome, ViralHerpesvirus 4, HumanHistonesHumansInsulator ElementsNeoplasmsReplication OriginVirus LatencyChromatinHistonesChromatinChromosome conformationCTCFDNA methylationEpstein–Barr virusGammaherpesvirusHistone modificationsOriP

Identifiers

PMID24468737
PMCPMC4048758
OpenAlexW2151876257

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.